Back to Search Start Over

Early clinical markers of aggressive multiple sclerosis.

Authors :
UCL - SSS/IONS/CEMO - Pôle Cellulaire et moléculaire
UCL - (SLuc) Service de neurologie
Malpas, Charles B
Manouchehrinia, Ali
Sharmin, Sifat
Roos, Izanne
Horakova, Dana
Havrdova, Eva Kubala
Trojano, Maria
Izquierdo, Guillermo
Eichau, Sara
Bergamaschi, Roberto
Sola, Patrizia
Ferraro, Diana
Lugaresi, Alessandra
Prat, Alexandre
Girard, Marc
Duquette, Pierre
Grammond, Pierre
Grand'Maison, Francois
Ozakbas, Serkan
Van Pesch, Vincent
Granella, Franco
Hupperts, Raymond
Pucci, Eugenio
Boz, Cavit
Sidhom, Youssef
Gouider, Riadh
Spitaleri, Daniele
Soysal, Aysun
Petersen, Thor
Verheul, Freek
Karabudak, Rana
Turkoglu, Recai
Ramo-Tello, Cristina
Terzi, Murat
Cristiano, Edgardo
Slee, Mark
McCombe, Pamela
Macdonell, Richard
Fragoso, Yara
Olascoaga, Javier
Altintas, Ayse
Olsson, Tomas
Butzkueven, Helmut
Hillert, Jan
Kalincik, Tomas
UCL - SSS/IONS/CEMO - Pôle Cellulaire et moléculaire
UCL - (SLuc) Service de neurologie
Malpas, Charles B
Manouchehrinia, Ali
Sharmin, Sifat
Roos, Izanne
Horakova, Dana
Havrdova, Eva Kubala
Trojano, Maria
Izquierdo, Guillermo
Eichau, Sara
Bergamaschi, Roberto
Sola, Patrizia
Ferraro, Diana
Lugaresi, Alessandra
Prat, Alexandre
Girard, Marc
Duquette, Pierre
Grammond, Pierre
Grand'Maison, Francois
Ozakbas, Serkan
Van Pesch, Vincent
Granella, Franco
Hupperts, Raymond
Pucci, Eugenio
Boz, Cavit
Sidhom, Youssef
Gouider, Riadh
Spitaleri, Daniele
Soysal, Aysun
Petersen, Thor
Verheul, Freek
Karabudak, Rana
Turkoglu, Recai
Ramo-Tello, Cristina
Terzi, Murat
Cristiano, Edgardo
Slee, Mark
McCombe, Pamela
Macdonell, Richard
Fragoso, Yara
Olascoaga, Javier
Altintas, Ayse
Olsson, Tomas
Butzkueven, Helmut
Hillert, Jan
Kalincik, Tomas
Source :
Brain, Vol. 143, no. 5, p. 1400-1413 (2020)
Publication Year :
2020

Abstract

Patients with the 'aggressive' form of multiple sclerosis accrue disability at an accelerated rate, typically reaching Expanded Disability Status Score (EDSS) ≥ 6 within 10 years of symptom onset. Several clinicodemographic factors have been associated with aggressive multiple sclerosis, but less research has focused on clinical markers that are present in the first year of disease. The development of early predictive models of aggressive multiple sclerosis is essential to optimize treatment in this multiple sclerosis subtype. We evaluated whether patients who will develop aggressive multiple sclerosis can be identified based on early clinical markers. We then replicated this analysis in an independent cohort. Patient data were obtained from the MSBase observational study. Inclusion criteria were (i) first recorded disability score (EDSS) within 12 months of symptom onset; (ii) at least two recorded EDSS scores; and (iii) at least 10 years of observation time, based on time of last recorded EDSS score. Patients were classified as having 'aggressive multiple sclerosis' if all of the following criteria were met: (i) EDSS ≥ 6 reached within 10 years of symptom onset; (ii) EDSS ≥ 6 confirmed and sustained over ≥6 months; and (iii) EDSS ≥ 6 sustained until the end of follow-up. Clinical predictors included patient variables (sex, age at onset, baseline EDSS, disease duration at first visit) and recorded relapses in the first 12 months since disease onset (count, pyramidal signs, bowel-bladder symptoms, cerebellar signs, incomplete relapse recovery, steroid administration, hospitalization). Predictors were evaluated using Bayesian model averaging. Independent validation was performed using data from the Swedish Multiple Sclerosis Registry. Of the 2403 patients identified, 145 were classified as having aggressive multiple sclerosis (6%). Bayesian model averaging identified three statistical predictors: age > 35 at symptom onset, EDSS ≥ 3 in the first year, and the presence

Details

Database :
OAIster
Journal :
Brain, Vol. 143, no. 5, p. 1400-1413 (2020)
Notes :
English
Publication Type :
Electronic Resource
Accession number :
edsoai.on1288286147
Document Type :
Electronic Resource